Fund Evaluator:
Brandes International ETF (BINV)Equity
Global Asset Class
International Equity
Fund Group
Foreign Large Value
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.70% F
Expense Ratio
$529 Mil
Assets
Open
Status
0.00%
12b-1 Fee
2.09%
TTM Yield
0.00%
Max Load
3%
Portfolio Turnover
Best Performing in Foreign Large Value Over the Last Year
| 48.8% | Smead International Value Inv (SVXLX) |
| 45.5% | Touchstone International Value Y (SIIEX) |
| 43.8% | GMO International Opportunistic Val I (IOVFX) |
| 41.7% | Carillon ClariVest Intl Stock I (EISIX) |
| 39.7% | Pzena International Value Investor (PZVNX) |
Data as of 7/31/2026
7.2% A
1-Mo Return
7.5% A
3-Mo Return
13.6% D
YTD Return
28.3% D
1-Yr Return
na
3-Yr Return
na
5-Yr Return
na
Category Risk Index
na
Total Risk Index
Fund Details
Fund Family
Brandes
Inception Date
10/3/2023
Share Class Type
Equity Investment Style
Large-Cap
Value
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
MSCI EAFE NR USD: 100%
Additional Fund Details
Brandes International ETF Overview
BINV Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| BINV Return (NAV) | 7.2% | 7.5% | 28.3% | na | na | na |
| BINV Grade | A | A | D | na | na | na |
| +/- Category | 3.3% | 1.6% | -2.6% | na | na | na |
| Foreign Large Value Avg | 3.8% | 5.9% | 30.9% | 19.3% | 12.2% | 9.8% |
| BINV Tax Cost Ratio | na | na | 0.9% | na | na | na |
BINV Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| BINV Return (NAV) | 13.6% | 37.6% | 7.4% | na | na | na | na | na | na | na | na |
| BINV Grade | D | C | A | na | na | na | na | na | na | na | na |
| +/- Category | -1.3% | -1.0% | 2.9% | na | na | na | na | na | na | na | na |
| Foreign Large Value Avg | 14.9% | 38.6% | 4.4% | 17.8% | -9.5% | 12.4% | 2.6% | 19.0% | -16.4% | 23.0% | 3.0% |
| Risk Measures | |
| Standard Deviation: | na |
| Total Risk Index: | na |
| Category Risk Index: | na |
| Category Risk Grade: | |
| Beta: | na |
| R-Squared: | na |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Value |
| Bond Investment Style: | na |
| Yield: | 2.1% |
| Dividend Distribution: | Quarterly |
| Cap Gains Distribution: | Annually |
| Total Assets: | $529 Mil |
| Fund Total Assets: | $ 530 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 3% |
Management Team
| Number of Managers: 5 | |||
| Longest Tenure: 2.8 years | |||
| Average Tenure: 2.8 years | |||
| Managers (Year): Sauerbronn Luiz (2023), Morris Amelia (2023), Omura Shingo (2023), Germain Jeffrey (2023), Woods Brent (2023) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 73 |
| % in Top 10 Holdings: | 23.3% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 96.3% |
Portfolio Allocation |
|
| Domestic Stock: | 1.9% |
| Foreign Stock: | 96.3% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 1.8% |
Purchase Information
| Fund Family: | Brandes |
| Phone Number: | 866-307-0477 |
| Website: |
| Status: | Open |
| Inception Date: | October 3, 2023 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | 0.00% |
Expenses and Fees | |
| Expense Ratio (%): | 0.70% ( Rating : Above Avg ) |
| Category Average Expense Ratio (%): | 1.05% |
| Share Class: | Brandes International ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.